Intravenous (IV) Solution Market Players:
The key players who are impacting the global Intravenous (IV) Solution in significant ways are ICU Medical, Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), Grifols S.A. (Spain) and others.
Market Insights:
The Intravenous (IV) Solution Market has witnessed continuous growth in the past few years, and it can grow ahead at a CAGR of 7.69% with achieving a valuation of USD 11,511.2 million during the forecast period 2016-2022. Intravenous (IV) solution is provided to the patients deficient in nutrients or cases of severe dehydration. Intravenous solutions are provided to a patient directly in the form of fluids, which must be sterile to protect patients from injury. The market is prospering with some of the essential factors that are backing the market efficiently.
Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1235
Global Intravenous (IV) Solution Market: Drivers & Trends
The growing incidence rate of chronic diseases, such as cancer, is a driving factor for this booming industry. With this, the demand for Total Parenteral Nutrition (TPN) is also increasing, which forms a vital part of the treatment. As per the research, cancer disease is forecasted to grow by 70% over the next decades, which poses a colossal growth prospect for the market during the forecast period.
In addition, intravenous solutions have been observed with technologies and designs that have improved its overall functionalities. With the recent development of packaged intravenous products has distinctly impacted the global market for intravenous solutions. The manufacturers are introducing IV fluids and compounds that can be mixed with other liquid medicines and solutions for aid. These factors are anticipated to continue to drive the global intravenous (IV) solution market substantially over the forecast period.
Furthermore, the growth of intravenous (IV) solution market is also influenced by the prevalence of chronic disorders as well as the growing popularity of IV led treatments and therapies intended towards curing cancer.
Market Segmentation
The global intravenous (IV) solution market is segmented based on type, nutritional content, and end-user market.
In terms of type, the market has been segmented as of total parenteral solution, peripheral parenteral solution.
In terms of nutritional content, the market has been segmented into the amino acid solution, carbohydrates, vitamins & minerals, parenteral lipid emulsion, and others.
In terms of end user, the market has been segmented into hospitals & clinics, ambulatory, and home care.
Browse Full Report at https://www.marketresearchfuture.com/reports/intravenous-solution-market-1235
Regional Outlook
Region-specific segmentation for the global Intravenous (IV) Solution market covers North America and Asia-Pacific.
North America brings in the largest market share since 2015 owing to the factors of high IV consumption number, high prevalence of chronic diseases. Due to these factors, the market is expected to reach USD 4,276.5 million in the forecast period.
Asia Pacific region has also observed the fastest growing market for Intravenous (IV) Solution, which has recorded a growth rate of CAGR of 8.34% during the forecast period 2016 to 2022. Major shifts are taking place in this region as the emergence of high-quality and better healthcare infrastructure and institutions.
Industry News
10 June 2019: CJ HealthCare, a subsidiary of Kolmar Korea, reported that it had invested 100 billion won ($84.3 million) into building a new factory to produce IV (intravenous therapy) fluids.
The construction of the new plant was CJ HealthCare’s first massive investment after being acquired by Kolmar Korea in April last year. The 32,893-square meter factory would be located in the company’s factory site within the Osong Life Science Complex in North Chungcheong Province.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
No comments:
Post a Comment